<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Surgery and Trauma</title>
<title_fa>نشریه جراحی و تروما</title_fa>
<short_title>J Surg Trauma</short_title>
<subject>Medical Sciences</subject>
<web_url>http://jsurgery.bums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2345-4873</journal_id_issn>
<journal_id_issn_online>2345-4873</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/jsurgtrauma</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1395</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2016</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>4</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Effect of Avastin on intraocular pressure before and after intravitreal injections</title>
	<subject_fa>چشم</subject_fa>
	<subject>Ophthalmology</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Introduction:&lt;/strong&gt; Intravitreal Avastin (bevacizumab) injection is reportedly accompanied by ocular and systemic side-effects. Our enquiry assesses whether there are any differences between intraocular pressure (IOP) in baseline and on the day after injection in patients treated for retinal disease.&lt;br&gt;
&lt;strong&gt;Methods:&lt;/strong&gt; In this experimental study, 82 eyes with retinal diseases that had indication for anti-VEGF and were treated with injections of intravitreal bevacizumab were taken as the case group, and 82 healthy eyes were considered as controls. The IOP was measured by non-contact tonometry in both the healthy eyes and the eyes with retinal diseases before and 24 hours after intervention. Data were analyzed by paired t test and independent t-test in SPSS 19.0 software. Significance level was set at P &lt;0.05.&lt;br&gt;
&lt;strong&gt;Results:&lt;/strong&gt; Results of the study showed that the mean IOP before injection was not significantly different in either groups (p=0.51). However, it was significantly lower after injection than before it in both case and control eyes (p&lt;0.01). The mean IOP changes before and after infusion in the case and control eyes did not differ significantly (p=0.30).&lt;br&gt;
&lt;strong&gt;Conclusions:&lt;/strong&gt; Our study did not find an increased IOP in bevacizumab-treated eyes when compared to fellow control eyes. Further studies with a greater sample size are needed to evaluate whether an increased number of ranibizumab injections is associated with IOP changes.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Bevacizumab, Intraocular pressure, Intravitreal Injections</keyword>
	<start_page>44</start_page>
	<end_page>46</end_page>
	<web_url>http://jsurgery.bums.ac.ir/browse.php?a_code=A-10-72-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Behrooz</first_name>
	<middle_name></middle_name>
	<last_name>Heydari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hb51958@yahoo.com</email>
	<code>10031947532846003286</code>
	<orcid>10031947532846003286</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Assistant Professor, Department of Ophthalmology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Saeed Reza</first_name>
	<middle_name></middle_name>
	<last_name>Heydari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>heydarisr29@gmail.com</email>
	<code>10031947532846003287</code>
	<orcid>10031947532846003287</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Optometry, Faculty of Optometry, Mashhad University of Medical Science, Mashhad, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Gholamhossein</first_name>
	<middle_name></middle_name>
	<last_name>Yaghoobi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>yaqubig@yahoo.com</email>
	<code>10031947532846003288</code>
	<orcid>10031947532846003288</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Professor, Department of Ophthalmology, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
